1 W. Gehring and M. Gloor, "Effect of topically applied dexpanthenol on epidermal barrier function and stratum corneum hydration. Results of a human in vivo study". Arzneimittelforschung., 2000.Evaluation de [effet sur la reconstruction par mesure de perte insensible en eau (Cirec/Lb18122-1] - 2018.
2 Évaluation du pouvoir hydratant par cornéométrie (Cirec/ Lb18031] -2018.
3 Évaluation de [effet nourrissant par mesure du film gras résiduel (Cirec/Lb18122-2]-2018.
4 Test consommateurs à grande échelle (IEC France Stb 18006] -2018.
5 Test d'usage sous contrôle médical (Cirec Lb17123]-2018.
6 K.L Korponyai C, Kovacs RK, Ems G, Dikstein S, 'Antiirritant pruperties of polyols and amino acids' 2011.
7 An observational, pruspective and multicentric studywith 2 visits (DO, D281. 40 subjects were included by 9 investigating oncologists, 2019.
8 Common Terminology Criteria for Adverse Events (CTCAE].
9 DLQI - Dermatology life quality index.
10 W. Gehring and M. Gloor, ""Effect of topically applied dexpanthenol on epidermal barrier function and stratum corneum hydration. Results of a human in vivo study"". Arzneimittelforschung., 2000. Évaluation de [effet sur la neconstruction par mesune de perte insensible en eau [Cinec/Lb18122-1] - 2018.
11 E. Proksch and H.P Nissen, ""Dexpanthenol enhances skin barrier nepair and neduces inflammation after sodium lauryl sulphate-induced irritation.," J. Dermatolog. Tneat., vol 13, no 4, pp. 173-178, 2002.
12 M.T Longaker, E.S Chiu, N.S Adzick, M.Stern, M.R Harrison, and R.Stern, ""Studies in fetal wound healing. V.A prolonged pnesence of hyaluronic acid characterizes fetal wound fluid.,"" Ann. Surg., vol? 213, no 4, pp 292-6, 1991.
13 Évaluation du pouvoir hydratant par cornéométrie [Cirec/Lb18127] - 2018.
14 Évaluation de [effet sur la reconstruction par mesure de perte insensible en eau [Cinec/Lb18036-2] - 2018.
15 K.L Korponyai C, Kovacs RK, Eros G, Dikstein S, "Antiirritant properties of polyols and amino acids" 2011. A multicenter, double blind, prospective, randomized controlled [1 :1 ratio] study with thnee visits [DO, 07 and 028] involving 70 subjects included by eight oncologists, 2019.
16 Tolerance acconding ta the subject evaluation.
17 DLQI - Dermatology life quality index.